Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ENZ 3.00 +0.05 (1.69%)
price chart
Enzo Biochem Inc. Files SEC Form SC 13G, Statement of Acquisition of ...
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a U.S.
Enzo Biochem, Inc. v. Applera Corp. (Fed. Cir. 2010)
Enzo The '824, '767, '928, and '830 patents, which are owned by Plaintiffs-Appellants Enzo Biochem, Inc., Enzo Life Sciences, Inc., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. More ...
Enzo Biochem Inc. (ENZ) Jumps 5.21% on March 30
Enzo Biochem Inc. ($ENZ) was among the biggest gainers on the Russell 2000 for Monday March 30 as the stock popped 5.21% to $3.03, representing a gain of $0.15 per share.
Enzo Biochem Inc. v. Applera Corp. (Fed. Cir. 2015)
This is what the Federal Circuit held earlier this week in the Enzo Biochem Inc. v. Applera Corp. case. Writing for the majority, Chief Judge Prost noted that the intrinsic evidence for a patent related to modifying polynucleotides to be used with ...
BRIEF-Patent verdict favoring Enzo Biochem is reversed by US appeals court
March 16 (Reuters) - Enzo Biochem Inc : * U.S. appeals court rules in favor of applera corp and against Enzo Biochem. Inc in patent infringement case -- court ruling * U.S.
Enzo Biochem stock plunges after $61M Applera judgment tossed
(Bloomberg) -- Enzo Biochem Inc. fell after an appeals court threw out a $61 million judgment it won against Thermo Fisher Scientific Inc.'s Applera unit over genetic research and screening.
Enzo Biochem, Inc. Short Interest Update
Enzo Biochem, Inc. (NYSE:ENZ), A rise of 23,782 shares or 2.7% was seen in the short interest of Enzo Biochem. Even as the interest increased from 867,380 shares on February 13,2015 to 891,162 shares on February 27,2015, the days to cover came in at 3 ...
Enzo Biochem Announces Appointment of James M. O'Brien as Senior VP ...
Jim has held leadership positions in the areas of planning and strategic development, financial analysis, SEC reporting and internal controls for both large and small multi-national public companies,� said Barry Weiner, President of Enzo Biochem, Inc ...
Healthcare Stocks Little Changed; Enzo Biochem, Innate Pharma Partnering on ...  NASDAQ
Related articles »  
Enzo Biochem Inc. (ENZ) is Trading Lower on Unusual Volume for March 16
Enzo Biochem Inc. ($ENZ) experienced unusually high volume on Mar. 16, as the stock lost 7.55% to a closing price of $3.06.
Stocks Taking Toll on Day- Enzo Biochem Inc. (NYSE:ENZ), Splunk, Inc ...  StreetWise Report
Hot and Soars Stocks: Enzo Biochem Inc. (NYSE:ENZ), Splunk, Inc. (NASDAQ ...  eMarketsDaily
Downward or Upward: Enzo Biochem (NYSE:ENZ)
Enzo Biochem Inc. (NYSE:ENZ) last traded at $2.98 after moving down -0.67% for the trading day. The company last released their quarterly earnings results on 03-12-15 for the period ended Jan-15.